Malcolm V Brock, M.D.

• Director of Clinical and Translational Research in Thoracic Surgery
• Professor of Surgery

https://www.hopkinsmedicine.org/profiles/results/directory/profile/0005064/malcolm-brock

Ocular pulsation may be visible and even palpable anxiety symptoms throwing up order discount imipramine online, as a result of transmission of the arterial pulse to the dilated ophthalmic veins and globe anxiety 4 year old boy imipramine 25 mg order with mastercard. Abnormalities in the ocular pulse can be seen with Goldmann applanation tonometry as wide to-and-fro movements of the mires anxiety fear imipramine 50 mg low cost. The wide pulse (up to five times normal) may also be documented with pneumotonometry anxiety icd 9 buy imipramine uk. The vessels have a corkscrew appearance and the tortuosity and dilatation extend all the way to the limbus anxiety symptoms uk order imipramine in united states online. Massive proptosis can lead to corneal and conjunctival exposure, which may then lead to ulceration. This may be aggravated by corneal hypoesthesia resulting from trigeminal nerve dysfunction. Arterialization of episcleral veins and subsequent elevation of episcleral venous pressure cause increased intraocular pressure and glaucoma. Rarely the intraocular pressure rise is precipitous and may result in central retinal artery occlusion. Other mechanisms responsible for the development of glaucoma include elevation of orbital pressure secondary to venous stasis and edema, anterior segment neovascularization and secondary glaucoma,126 and secondary angle closure resulting from congestion of the choroid and ciliary body and a forward shift of the iris diaphragm. The abnormal blood flow is usually directed to the eye ipsilateral to the fistula, but contralateral signs may develop due to connections between the two cavernous sinuses. In contrast, the third and fourth nerves are enveloped by dura in the lateral wall of the sinus. The oculomotor palsies may result from compression or from ischemia related to altered blood flow in the vasa nervora. Many patients describe pain in the first or sometimes second division of the trigeminal nerve, most likely caused by compression of the ophthalmic and maxillary divisions of the fifth nerve in the cavernous sinus. Some patients develop diplopia from restrictive myopathy secondary to orbital congestion. The extraocular muscles are enlarged and the diplopia is coincident with the development of proptosis. In many patients, a combination of neurogenic and myopathic eye movement dysfunction occurs. Forced duction testing with forceps should not be performed because of the risk of bleeding from arterialized conjunctival and episcleral vessels. Other causes of vision loss include anterior ischemic optic neuropathy, compressive optic neuropathy from distended veins, and retrobulbar ischemia. If drainage occurs superiorly into the sphenoparietal sinus or deep sylvian veins, spontaneous rupture may be associated with intracerebral or subarachnoid bleeding. Doppler ultrasonography may demonstrate reversal of flow in the superior ophthalmic vein. Although the diagnosis can be established by the classic clinical findings and with noninvasive studies, formal cerebral angiography is usually required to show the extent and location of feeding vessels. Angiography helps identify the presence of pseudoaneurysms, define the pattern of venous drainage, and establish the presence of any cavernous sinus thrombosis. The presence of contributing dural collaterals or a patent primitive trigeminal artery, the patency of the circle of Willis, and the amount of collateral flow from the contralateral carotid must also be evaluated and considered before treatment. Without treatment, there is significant risk for serious vision loss secondary to exposure, glaucoma, and venous stasis. Most authors agree that progressive vision loss, proptosis, ophthalmoplegia, elevated intracranial pressure, intracranial bleeding, and epistaxis are all indications for treatment. Glaucoma is treated with topical medications including (b-blockers, topical or oral carbonic anhydrase inhibitors (a2-specific adrenergic agents, and prostaglandin analogs. None of these is directed at the primary cause of the elevated intraocular pressure, and therefore only modest reductions in intraocular pressure may result. In general, filtering procedures should be avoided because precipitous lowering of intraocular pressure in eyes with dilated choroidal vessels could result in suprachoroidal hemorrhage. Canthotomy and cantholysis can be used to decompress the orbit temporarily before more definitive treatment is initiated. Corneal exposure should be managed with aggressive lubrication and possibly tarsorrhaphy. Transarterial occlusion with detachable balloons was first used by Serbinenko in 1974. Endovascular treatment preserves carotid artery patency and is successful in 59­88% of patients. Transvenous embolization can be performed through the femoral vein or through the orbit. Orbital echography may be used to document enlarged superior ophthalmic veins and extraocular muscles. A-scan ultrasonography may demonstrate rapid echo spikes within the superior ophthalmic vein when done in real time. Complications from all treatment modalities include pseudoaneurysm formation and oculomotor palsies. Recurrence of the bruit or persistent elevated intraocular pressure suggests that the fistula has recurred or was inadequately treated. Visual-field defects from glaucomatous optic neuropathy, ischemic optic neuropathy, or central retinal artery occlusion would not be expected to improve. Improved diagnostic studies and a better appreciation of its manifestations have led to increased awareness of this entity. Carotid dissection or dissecting carotid aneurysm results from entrance of intraluminal blood into the arterial wall through a break in the intimal layer. Ultimately, expansion of the pseudolumen may compromise flow through the normal lumen. Neuroophthalmic manifestations include painful Horner syndrome, cranial nerve palsies, visual disturbances, and transient ischemic attacks. The condition was thought to be rare until Fisher and co-workers reported a series of 16 patients and reviewed the literature in 1978. With varying sensitivity and specificity, these techniques establish the diagnosis and determine the extent of the lesion. Multiple neurologic and neuroophthalmic signs and symptoms may develop, depending on the extent of the dissection. Nine of 24 patients in one series had ocular symptoms including Horner syndrome, eye pain, and amaurosis fugax. Vision loss may result from central retinal artery occlusion, ocular ischemic syndrome, or posterior ischemic optic neuropathy. Findings include nonatherosclerotic arterial abnormalities such as narrowing, a membrane crossing the vessel lumen, and an intimal flap. In cases that involve intracranial hemorrhage or persistent emboli despite maximal medical therapy, endovascular treatment may be necessary. The clinical presentation and management of these lesions are summarized in Table 289. Mokri and associates found complete clinical and angiographic recovery in 85% of their patients, regardless of treatment modality. Recurrence is more common in patients with predisposing factors that weaken blood vessel walls, such as fibromuscular dysplasia. In patients with a history of symptoms for more than 1 week and without transient neurologic dysfunction, aspirin therapy alone may be sufficient. There have been no prospective studies evaluating the most effective therapy for carotid dissection. The vessel feeding or draining the lesion may be intracranial or extracranial, and the majority of intracranial lesions involve pial vessels only. The lesions commonly have their base on the surface of the brain and extend to various depths within the underlying parenchyma. The intervening cerebral tissue is often gliotic, and the surrounding neural tissue characteristically shows some degree of atrophy. Malformations often become symptomatic during times of hormonal fluctuation, accelerating growth, or increased intravascular volume, such as puberty or pregnancy. Neurologic symptoms are usually the result of posterior circulation abnormalities and include vertigo, confusional state, ataxia, dysphagia, and dysarthria. Lateral medullary infarction, resulting from distal vertebral embolization (with subsequent obstruction of the posterior inferior cerebellar artery), is a wellrecognized complication. A review of 51 separate episodes of vertebral artery dissection seen at the Mayo Clinic found that 86% of patients had ophthalmic signs or symptoms. The most common ophthalmic symptom was diplopia, occurring in 45% of the episodes. Other reported symptoms were blurred vision, transient visual dimming, and oscillopsia. Findings on examination included nystagmus, incomitant strabismus (cranial nerve palsy or skew deviation), Horner syndrome, corneal hypoesthesia, and ptosis. Catheter angiography can be helpful to confirm the initial diagnosis made with noninvasive technologies. Treatment is generally with heparin followed by warfarin, or simply antiplatelet therapy with aspirin alone or with aspirin and Plavix. This lack of correlation is most likely due to the remote effects of these lesions. Neuroophthalmologic Presentation and Management of Vascular Malformations Lesion Arteriovenous malformation Presentation Vision loss: Transient photopsias, hallucinations, monocular blindness, or hemianopia; acute or progressive field loss consistent with pre- or postgeniculate lesion: elevated intracranial pressure, compression, or hemorrhage Ocular motor and orbital: Cranial nerve palsies, supranuclear gaze dysfunction, ptosis, chemosis, and proptosis Ocular motor and orbital: Rare symptoms related to brain stem dysfunction (pons) Vision loss: Extremely rare unilateral or bilateral vision loss resulting from anterior pathway lesions Ocular motor and orbital: Skew deviation, supranuclear gaze paresis, nystagmus, and intermittent proptosis Vision loss: Unilateral and bilateral vision loss from optic nerve and chiasmal lesions; papilledema related to elevated intracranial pressure Ocular motor and orbital: Cranial neuropathies, supranuclear gaze paresis, skew deviation, and dorsal midbrain syndrome resulting from brain stem involvement; proptosis, diplopia, and gaze evoked amaurosis caused by orbital lesions Management Surgery: Complicated for large mesial temporal and deep lesions Embolization: Poor outcome alone; adjuvant therapy with surgery or radiosurgery Radiosurgery: Excellent results for lesions <3 cm; may be combined with surgery or embolization; slow rate of therapeutic action Observation Conservative: Observation in a large majority of cases Surgery: Indicated for intracranial and orbital lesions that are symptomatic and progressive Capillary telangiectasia Venous angioma Cavernous hemangioma Conservative: Large majority of cases Surgery: Indicated for superficial intracranial lesions and symptomatic intraorbital lesions distant neural tissue through a vascular steal phenomenon. Ocular motility abnormalities are frequent with posterior fossa lesions but overall are infrequent because of the relatively low proportion of these lesions. Additional neuroophthalmologic symptoms include papilledema, pupillary abnormalities, supranuclear gaze palsies, proptosis, lid dysfunction, and optic atrophy (see Table 289. Transient symptoms include monocular blindness, photopsias, visual hallucinations, and transient hemianopias. The pattern and timing of the visual changes often suggest the location of the malformation. Photopsias and hallucinations often occur as release phenomena within a deficient visual field, but in some instances they can occur in isolation. On occasion, visual symptoms may be accompanied by a headache simulating migraine. Therefore, a careful history of the onset, spread, duration, and temporal relationship of visual symptoms to headache can be critical in determining the need for neuroimaging in a patient who complains of headache and visual changes. Patterns of vision loss consistent with either pregeniculate or postgeniculate dysfunction are possible. Anterior pathway dysfunction can result in bitemporal ischemic retinopathy, optic neuropathy, homonymous hemianopias, and hemianopias. The optic atrophy resulted from the direct involvement of the lateral geniculate nucleus in two cases and transsynaptic degeneration in the third. Chimowitz and co-workers reviewed a series of six patients presenting during a period of 10 years with papilledema. The lesions were all high-flow malformations feeding into the superior sagittal sinus. The pathogenic mechanism was thought to be mass effect in two and venous hypertension in the remaining four. Proptosis results from increased intraorbital arterial flow, decreased venous drainage, or both. Cerebral angiography remains the procedure of choice for demarcating the vascular anatomy before treatment. Morbidity and mortality remain high, and good outcomes occur in only 50% of cases. Modern endovascular techniques may change the prognosis for these lesions significantly. Appropriate studies must be selected to define adequately the anatomy of the lesion, the direction of vascular flow, and the effect of the malformation on adjacent and distant structures. In cases with ocular symptoms, ultrasonography may be useful in diagnosing orbital or cavernous lesions. The choice of therapy depends on the size and location of the lesion and the clinical characteristics of the patient. Staged therapy employing embolization or radiosurgery before surgical excision has yielded favorable results. Benefits include decreased bleeding, decreased lesion size, and diminished vascular steal. Ocular manifestations include papilledema, optic atrophy, oculomotor dysfunction, and proptosis. A hyperintense signal focus surrounded by a rim of signal void (open arrow) is characteristic of either slow flow or early chronic hemorrhage. Within the lesion, areas of highvelocity signal loss (small open arrows) are intermixed with brain parenchyma (small black arrows) and gliotic tissue (high-signal areas; small white arrows). Their results were quite favorable compared with results of surgical treatment of similar lesions. Embolization can be used before radiosurgery to reduce the lesion to smaller nidi less than 3 cm. In those individuals, multiple dermal, mucosal, and visceral telangiectasias point to the diagnosis. The necessity of treatment depends on symptoms, and only superficial lesions are amenable to surgery. Reports of clinical manifestations in the older literature are usually due to misdiagnosis or the presence of multiple lesions of different types. For example, there is a known association between venous malformations and cavernous malformations.

When ocular motility is minimally affected anxiety scale 0-10 25 mg imipramine purchase otc, a careful study of eye movements before and after intravenous injection of Tensilon may be particularly helpful in diagnosis anxiety symptoms eye pain imipramine 25 mg buy free shipping. Small changes in saccadic accuracy anxiety symptoms checklist pdf cheap imipramine 50 mg fast delivery, particularly the development of saccadic hypermetria anxiety symptoms generalized anxiety disorder quality 50 mg imipramine, suggest myasthenia anxiety symptoms flushed face generic imipramine 25 mg buy line. Saccadic fatigability during repetitive refixations or optokinetic nystagmus, which is reversed by Tensilon, is also a useful sign. Although the original description of this test by Osserman and Kaplan50 included no report of any complications, van Dyk and Florence51 accumulated a list of side effects by conducting a telephone survey of 25 neuro-ophthalmologists. A 50-year-old man became faint and then unresponsive ~1 min after Tensilon was injected. Cardiopulmonary resuscitation was begun, and the patient was revived without difficulty and without any permanent sequelae. In addition to these major reactions, minor side effects of Tensilon testing include fainting, dizziness, and involuntary defecation. Although most side effects associated with the Tensilon test can probably be prevented by pretreating patients with an intramuscular injection of atropine sulfate, the conclusions of van Dyk and Florence51 was such that these reactions are exceedingly rare. The Tensilon test should also be avoided in older patients, particularly those with known cardiac disease, unless intravenous access and cardiac monitoring is in place. In others, however, there was no other evidence of myasthenia, and the response to Tensilon was thought to be falsely positive. For this reason, it is advisable to perform neuroimaging in all patients with isolated, unilateral ophthalmoparesis. In patients suspected of having myasthenia, a negative Tensilon test should be followed either by a Prostigmin test or by other diagnostic tests. Patients have been observed to have several negative Tensilon test results before a positive Tensilon result. Additionally, patients have been observed to have multiple unequivocally negative Tensilon test results, but other evidence of myasthenia. Because of the transient nature of ocular (and systemic) changes in muscle strength that occur after administration of Tensilon, the Prostigmin test remains an exceptionally valuable method of diagnosing myasthenia, particularly in patients with diplopia but without ptosis. The longer duration of the effects of this drug is sufficient to permit repeated testing of muscle strength and evaluation of ocular motility. When there is only minor ophthalmoparesis, it is important to perform quantitative measurements of ocular motility before and after Prostigmin injection. These measurements are repeated 30­45 min after intramuscular injection of Prostigmin. The extent of the difference between preinjection and postinjection measurements determines whether the test is positive or negative. The Prostigmin test is particularly helpful in the diagnosis of myasthenia in children, as intravenous injection of Tensilon may be accompanied by crying and lack of cooperation, precluding any meaningful assessment of its effect. In such patients, Prostigmin is injected and by the time the Prostigmin takes effect, the child has stopped crying and can be observed and the eye movements measured if necessary. In children, the amount of Prostigmin given is related to body weight and is usually 0. As with Tensilon, a positive Prostigmin test usually, but not always, indicates myasthenia; it has been reported in patients with brain stem tumors, multiple sclerosis, or congenital ptosis. Conversely, a negative Prostigmin test, like a negative Tensilon test, does not rule out myasthenia. Supramaximal electric stimuli are delivered at a rate of 2­3 Hz to the appropriate nerves, and compound muscle action potentials are recorded from muscles. Some investigators have reported decremental responses in as few as 41% of patients with known myasthenia, depending on the technique used and the severity of myasthenia in sampled patients. End-plate potentials reach the threshold for triggering an action potential of the muscle fiber with random variability, and this results in a variable latency between a nerve stimulus and the action potential of the responding muscle fiber. The latencies of responses of fibers belonging to the same motor unit are therefore not quite synchronous. The variability between any fiber and a reference fiber from the same unit is called jitter. When the safety factor for transmission is low, these latency variabilities (jitters) are increased. False-positive results are extremely rare but sometimes occur in patients with amyotrophic lateral sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. There are three classes of AchR antibodies that can be assayed: binding, blocking, and modulating. AchR binding antibodies react with antigenic sites on the AchR that are separate from the Ach binding site. These antibodies can activate the complement cascade and cause tissue damage and receptor loss. AchR modulating antibodies cross-link Ach receptors and increase the rate of their removal from the muscle membrane via endocytosis. AchR blocking antibodies were only seen in 52% of myasthenic patients, but there was a correlation between blocking antibodies and generalization of myasthenia. Drawing of the results of an electromyogram during repetitive nerve stimulation in a normal subject (a), in a patient with myasthenia (b), and in a patient with the Lambert­Eaton myasthenic syndrome (c). Note the decremental response in myasthenia and the facilitation response in the myasthenic syndrome. Increased jitter may have causes other than defective neuromuscular transmission. On the other hand, if a clinically weak muscle has normal jitter at all end-plates, the diagnosis of myasthenia can be excluded. Computed tomography and magnetic resonance imaging are probably equally sensitive. In addition, a complete blood count, erythrocyte sedimentation rate, antinuclear antibody test, and thyroid function tests should be performed because of the increased prevalence of other autoimmune diseases in myasthenic patients. Because systemic corticosteroids may be used in the treatment of myasthenia, any patient suspected of having this disorder should be tested for diabetes mellitus and should undergo a skin test for tuberculosis, because both diseases could be worsened by the administration of systemic corticosteroids. Disorders of the thyroid gland, including subclinical disease indicated by serum antibody studies, are more frequent in a myasthenic population than in a normal population. Other autoimmune disorders also occur more commonly in patients with myasthenia than in the normal population. Rheumatoid arthritis and ankylosing spondylitis are common in myasthenic patients and their relatives. Aplastic anemia associated with a thymic tumor can occur in patients with myasthenia, as can pernicious anemia. In general, patients with only ocular manifestations at onset who develop systemic manifestations do so within 2 years; however, there are too many exceptions to this rule to reassure patients or clinicians. Treatment includes cholinesterase inhibitors, thymectomy, immunosuppressive drugs, and, for patients with ocular manifestations, local therapy. Treatment must be individualized and should be supervised by a neurologist, preferably one who specializes in neuromuscular diseases. Anticholinesterase agents are the first-line therapy for patients with myasthenia. Although most patients experience some benefit from anticholinesterase agents, the response is often incomplete, particularly in patients with ocular manifestations, necessitating additional therapy (Table 295. A sustained- 4066 release anticholinesterase preparation, Mestinon Timespan 180 mg, is available; however, because of its irregular absorption, it should be used only for nighttime dosing in patients who have weakness during the night or on awakening. Anticholinesterases are safe, well-tolerated drugs, although they should be used with caution in patients with asthma or cardiac conduction defects. The most common side effect is diarrhea, which is dose-related and which can be controlled with diphenoxylate or loperamide once or twice a day. Excessive amounts of anticholinesterases may cause increased weakness that is reversible after decreasing or discontinuing the drug. Thymectomy is recommended for patients with generalized myasthenia in two settings. First, patients between puberty and 50 years of age whose disease is inadequately controlled with Mestinon alone may benefit from thymectomy. Thymectomy results in clinical improvement in ~85% of such patients, with drug-free remission in up to 35% and reduced medication requirements in up to 50%. The benefit from thymectomy is delayed, however, rarely occurring within 6 months and usually requiring 2­5 years for demonstrated efficacy. The surgery is more difficult in older patients, and such patients are less likely to improve after thymectomy. Thymectomy is an elective procedure and should be performed when the control of myasthenia is optimal. Patients with significant weakness often benefit from a course of plasmapheresis weeks to days before planned surgery. Plasmapheresis may also be necessary after surgery if patients have significant postoperative weakness. This avoids poor wound healing as well as the potential risk of postoperative infection related to immunosuppression. If immunosuppressive therapy after thymectomy is indicated, it is generally begun 2­6 weeks postoperatively for prednisone or 1­2 weeks postoperatively in the case of azathioprine (Imuran) or Cellcept. The risks of thymectomy include injury to the phrenic or recurrent laryngeal nerves, atelectasis, pleural effusion, pneumonia, myasthenic crisis, intercurrent pulmonary embolism, impaired wound healing, and late sternal instability. When anticholinesterase agents are ineffective and thymectomy is unwarranted or cannot be performed, several drugs can provide chronic immunosuppression: prednisone, azathioprine, cyclosporine, and mycophenolate mofetil. The choice among them is made by considering two factors: (1) how the toxicity profile fits the patient and (2) how fast the patient must improve. Corticosteroids can affect all aspects of weakness from diplopia to severe respiratory involvement. Diplopia, rarely corrected by anticholinesterase agents alone, responds well to steroid treatment. Some patients with moderate to severe generalized weakness or respiratory insufficiency are at risk of a transient steroidinduced exacerbation within 5­10 days and may need to be admitted to hospital for initiation of steroid therapy and observation. Once the patient achieves stabilization, switch to alternate day dosing using the lowest dosage possible. It is important to be aware of the side effects of chronic steroid therapy such as osteoporosis, weight gain and cushingoid habitus. Azathioprine can be used as initial therapy but beneficial effects may take 6 months to appear. Azathioprine usually is initiated if symptoms are still not controlled after thymectomy and on corticosteroid therapy. Patients on azathioprine need to have close medical monitoring due to side effects such as abnormal liver functions and bone marrow suppression. If this is well tolerated, gradually increase by 50 mg/week while monitoring the white blood cell count, differential count, platelet count, and liver function tests. Cyclosporine is a cyclic polypeptide that inhibits activation of helper/inducer T-cells and the production of cytokine interleukin-2. Improvement of symptoms with cyclosporine can begin at 2 weeks with maximum improvement by 4 months. The dosage is given in a divided schedule to minimize peak drug levels starting at 2. In a study by Tindall et al, cumulative side effects caused 35% of patients to discontinue the medication; 10% stopped the medication due to slowly progressive nephrotoxicity. Dosing is adjusted for severe renal failure given that the major route of excretion is through the kidney. Two case reports, two retrospective analyses, an open-label trial and one double-blind, randomized controlled trial have thus far evaluated the utility of mycophenolate for myasthenia. However, mycophenolate appears promising because these patients had a significant steroid dosage reduction. The mycophenolate dose used in these clinical trials was 1000 mg twice daily (range 1000­3000 mg/day). There were not any serious adverse side effects and the most common side effect was diarrhea. The beneficial effect from mycophenolate is reported as early as 2 weeks or as late as 9 months after initiating treatment. Plasmapheresis is primarily used to stabilize patients in myasthenic crisis or for short-term management of patients undergoing thymectomy, to avoid corticosteroids and immunosuppressants. Plasmapheresis works rapidly in patients with myasthenia, with objective improvement measurable within days of treatment. The beneficial effects of plasmapheresis are temporary, lasting only days to weeks, unless concomitant immunosuppressive agents are used. The effect is transient but may be sustained for weeks to months, allowing intermittent chronic therapy. Ptosis, the single most frequent finding and complaint, may be reduced in many patients by placing a wire attachment on the top of one or both sides of a spectacle frame to keep the eyelids elevated. This is particularly true when the amount or type of medication required to relieve the ptosis has intolerable side effects. Ptosis repair surgery can be performed in some patients with myasthenia, particularly patients who are refractory to appropriate medical therapy, thymectomy, or both or in whom ptosis is the only (or predominant) finding; however, success is sometimes short-lived because myasthenic ptosis is variable and can recur. Some patients with intermittent diplopia may require no therapy, but most are sufficiently bothered that some type of treatment is usually necessary. In patients with diplopia along a relatively fixed plane, prisms can be used, particularly when there is a relatively comitant deviation. Some patients may be content to wear prisms that correct their diplopia only in primary position. Extraocular muscle surgery is rarely warranted in patients with myasthenia and diplopia unless the strabismus has been stable for at least a year and no other treatment options are available.

The position of the lid margin in extreme downgaze is noted on a ruler held next to the eyelid anxiety icd 10 buy imipramine 25 mg low cost, and the patient is then asked to look up to the ceiling anxiety symptoms mimic ms 25 mg imipramine purchase overnight delivery. The distance that the lid margin travels in millimeters is termed the levator excursion and is indicative of the degree of levator function present anxiety symptoms checklist pdf 75 mg imipramine purchase visa. The amount of function can be classified as poor if it is 4 mm or less anxiety pain proven 75 mg imipramine, fair if 5­7 mm anxiety levels order imipramine 25 mg without a prescription, good if 8­12 mm, and excellent if 13 mm or more (Table 303. The presence of lid lag or lagophthalmos is also helpful in clarifying the etiology of the ptosis. The presence of this finding is particularly characteristic of the myogenic type of congenital ptosis due to fibrosis in the muscle. Once the external examination is completed, a slit-lamp evaluation should be attempted if possible. The quality of the tear film should be assessed, and the cornea examined for signs of exposure. A significant incidence of with-the-rule astigmatism occurs secondary to the weight of the ptotic lid against the globe. Traditionally, many surgeons have recommended delaying intervention until the age of 4­5 years, just prior to entering school. Some have argued that an older child permits a more accurate surgical evaluation and that surgical eyelid anatomy is better defined allowing for more satisfactory results. This reduces the emotional trauma often experienced by older children and is also beneficial to the parents who can more easily manage a younger child postoperatively. Most importantly, early surgery permits these younger surgical patients to achieve more normal visual, motor, and social development once their ptosis has been corrected. In addition, the possibility of a secondary synkinesis problem further supports delaying surgery. Classification of Levator Function Levator Function Excellent Good Fair Poor Eyelid Excursion 13 mm or greater 8­12 5­7mm 4 mm or less There are two major approaches to ptosis repair. The first approach requires strengthening the retraction mechanism within the eyelid, and the second requires the use of alternate anatomic structures in order to lift the lid. Strengthening the retraction mechanism requires some adjustment to one or more of these components. The second approach utilizes structures outside the eyelid for elevation of this structure. The first approach can be further divided topographically into internal (posterior) and external (anterior) approaches. The choice of procedure can be based on the degree of levator function and the response of the ptotic lid to the phenylephrine test. An excellent response to phenylephrine indicates that an internal approach may be quite effective and will usually mimic the lid level produced preoperatively by phenylephrine stimulation. Internal procedures include the conjunctivo-Müllerectomy (Fasanella­Servat), tarsoconjunctivo-Müllerectomy (Putterman), and the Müller-levator muscle resection (Werb) procedures. All of these procedures attempt to tighten the retraction mechanism within the eyelid approached from its posterior surface. If the response to phenylephrine is poor, then an external approach for levator advancement, levator resection, or a frontalis suspension procedure will be required. In the pediatric setting, this is particularly important as surgery is performed under general anesthesia and there is no opportunity for patient cooperation in intraoperative adjustment. An additional advantage is the minimal lagophthalmos observed postoperatively with these procedures. The selection of operation based on levator function and response to phenylephrine is summarized in Tables 303. This approach can be applied to all forms of ptosis though each etiology may help narrow the choice of procedures. Neurogenic and mechanical ptosis requires additional consideration in choosing a surgical approach. In the Marcus Gunn synkinetic jaw-wink syndrome, when synkinetic excursions are less than 2 mm, the surgical approach is similar to myogenic ptosis. When the abnormal lid movement is significant, the traditional approach for this problem has been a frontalis sling with extirpation of the levator. Selection of Ptosis Repair Based on Levator Function Levator Function Excellent (13 mm) Good (8­12 mm) Fair (5­7 mm) Poor (4 mm) Procedure Aponeuroric advancement Aponeuroric advancement, or moderate levator resection (14­17 mm) Large levator resection (18­22 mm) Frontalis suspension preferred Maximal/supramaximal levator resection (as alternative) After Beard C: Newer ptosis procedures. Another debate persists over whether frontalis suspension should be bilateral even for unilateral cases. Parents should be well informed of all options and participate in the choice of procedure. Surgery for mechanical ptosis is designed to address the specific cause of the malposition. If the ptosis is due to a capillary hemangioma, for example, surgery may be delayed for a trial of intralesional or systemic steroids. Other lesions such as lymphangioma or plexiform neurofibroma, however, often require surgical debulking if the central visual axis is compromised. By adjusting the amount of tissue in the clamp, the surgeon can correspondingly alter the elevation achieved. It is important to leave at least 4 mm of tarsus, however, in order to avoid destabilizing the eyelid, which can then cause an entropion. Modified Fasanella­Servat procedure: (a) Clamps placed with 4­0 silk traction sutures. The tissue is resected below the clamps above the suture line and the second arm of the absorbable suture is then utilized to approximate the wound edges. Both arms of the suture are then passed through the conjunctival wound to the skin surface and tied externally. In this fashion, one can produce higher lid level if the response to phenylephrine has been slightly undercorrected. Depending upon the amount of the levator muscle to be removed, the horns may or may not be cut with this technique. It also does not permit simple levator aponeurosis advancement, which is sometimes the procedure of choice. Excess conjunctiva may then be resected to avoid prolapse, and the remaining edge can be reattached to the superior tarsal border with interrupted 6. The placement of the mattress sutures should be through partial thickness tarsus, no more than one-third below the superior margin in order to avoid a buckling of the tarsus. The lid is set in relation to the superior corneal limbus based on the amount of levator function and degree of ptosis (Table 303. Once appropriate height and contour are achieved, the excess levator muscle is resected and the sutures tied in position. The lid crease may be created by placing one arm of the mattress suture through the dermis of the pretarsal skin. Levator muscle resection (a) the scissor blades should engage the end of the clamp. The gold standard for frontalis suspension has always been considered to be the use of autogenous fascia lata for permanent support. Given the morbidity of harvesting fascia in younger children, there has been an increased interest in the use of other materials in order to elevate the lid via frontalis suspension. This has included the use of donor fascia as well as a variety of synthetic implants. Long-term reviews of lyophilized fascia lata, indicated decline of surgical success from 90% at 3 years to 50% at 9 years. Nevertheless, there has still been a recurrence of 28% reported in cases with an average follow-up time of 3 years. This allows the patient some vision through a narrowed lid fissure medially, as well as room for the parents to apply antibiotic ointment to the eyes. All of these materials may be considered alternatives to autogenous fascia lata or when a child is too young, and each has advantages and disadvantages specific to the material. A discussion of the use, effectivity, and morbidity of each material is beyond the scope of this chapter. A more complete discussion of this is beyond the scope of this chapter but can be reviewed in a number of useful publications. Recurrent ptosis is encountered with greatest incidence in frontalis suspension repair when synthetic materials are implanted, ranging from 26% to 40%. As previously discussed, one of the advantages of the Müllerectomy surgery is the lower frequency of postoperative lagophthalmos. Extensive levator resections, on the other hand, quite commonly produce lid lag and lagophthalmos. This problem is also common, though less severe and often less chronic, with frontalis suspensions. Parents need to be made aware of the risk of lagophthalmos postoperatively and need to be educated to properly lubricate the cornea. Whereas those patients who undergo Müllerectomy have very little risk for exposure keratopathy, those patients undergoing levator or frontalis ptosis repair need aggressive corneal protection. Frequent lubrication may not be sufficient in these patients to prevent corneal injury in the immediate postoperative period and either a reverse Frost or suture tarsorrhaphy is necessary. J Fr Ophthalmol 1995; 18:207­219 McLeish W, Patel B, Anderson R: Congenital blepharoptosis surgery. Robb In this article, both deficiency of tears and excess tear production in infancy are discussed. Major attention is given to the most common abnormality of the lacrimal system in childhood, congenital nasolacrimal duct obstruction, its natural course, and its management. A few cases of more severe and evidently permanent deficiency of reflex and psychic tearing have been reported in otherwise healthy individuals, usually in association with some photophobia and irritation of the eyes. The condition is inherited in an autosomal recessive pattern and is found almost exclusively in families of Ashkenazic Jewish ancestry. The deficiency of tears appears to be the result of altered parasympathetic innervation of the lacrimal gland, and the pupils exhibit supersensitivity to dilute solutions of parasympathomimetic drugs: 2. Although such pupillary sensitivity supports the diagnosis of Riley­Day syndrome, it is not pathognomonic. Tearing and photophobia are occasional signs of infantile glaucoma, along with an enlarged, hazy cornea and elevated intraocular pressure. Excess lacrimation can also be produced by the paradoxical gustolacrimal reflex, a rare abnormal linkage between the salivary and lacrimal glands. In the presence of this link stimuli that produce salivation, such as chewing and sucking, also cause abnormal lacrimation. The phenomenon may be acquired after trauma to the facial nerve, but it also occurs as a congenital lesion associated with lateral rectus muscle paralysis. Efforts to find or create a canaliculus when no punctum is evident are not usually successful. In this case the punctum can be identified, but a thin membrane obstructs its lumen. The membrane can usually be perforated with a fine punctum dilator, and a probe can then be passed easily along the canaliculus toward the lacrimal sac. Lateral displacement of the inferior lacrimal puncta without obstruction is a feature of the Waardenburg syndrome, an autosomal dominant condition also characterized by iris heterochromia, a white forelock, and sensorineural hearing loss. Congenital cutaneous lacrimal fistulae occur occasionally along the course of the upper lacrimal drainage system. The skin opening may connect to a lacrimal canaliculus or the lacrimal sac, and tears may be seen to emerge from it. Fistulae can usually be excised with a small ellipse of adjacent skin and sutured closed primarily. The usual obstruction is at the lower end of the duct, where the epithelium of the lacrimal duct and the mucosa of the nose abut each other and form an imperforate membrane. In the presence of such obstruction tears well up and overflow the eyelids, and a variable amount of mucopurulent discharge develops. Although eyelid irritation may occur, there is characteristically no redness or inflammation of the conjunctiva, such as is seen in neonatal conjunctivitis or chemical irritation. The diagnosis of nasolacrimal duct obstruction is usually evident from overflow of tears, but in questionable cases fluorescein dye can be instilled in the conjunctival cul-de-sac and its disappearance time assessed. Spontaneous remission of congenital nasolacrimal duct obstruction (1019 eyes followed). Each column represents the number of eyes that showed resolution of symptoms during that month of life. Massage over the sac usually results in retrograde expression of discharge onto the eye by way of the canaliculi. Occasionally purulent material in the sac can be pushed downward through the duct into the nose, breaking through the duct obstruction with a sudden popping sensation. From Rochon-Duvigneaud: Dilatation of the tearducts in the fetus and newborn following perforation of the inferior cavity: anatomical conditions which favor dacryocystitis. It can be done when the tearing and discharge become troublesome enough to warrant surgical resolution. The high rate of spontaneous clearing in the first year weighs against early surgery. Because spontaneous clearing declines after 1 year of age and most parents tire of dealing with the discharge by that time, there is little reason to delay probing beyond the end of the first year. Conversely, if the tearing and discharge are copious and irritating, probing may be indicated before then. The procedure can be done with the child under topical or general anesthesia, but the latter is usually preferred for children over 6 months of age.

Order imipramine line. Sports Performance Anxiety and Athletes.

Luda E anxiety zone breast cancer buy 50 mg imipramine fast delivery, Bo E anxiety chest tightness generic 25 mg imipramine visa, Sicuro L anxiety symptoms throat closing 75 mg imipramine order amex, et al: Sustained visual aura: a totally new variation of migraine anxiety symptoms generalized anxiety disorder 75 mg imipramine order otc. May A anxiety symptoms preschooler generic imipramine 50 mg without a prescription, Bahra A, Buchel C, et al: Hypothalamic activation in cluster headache attacks. Leone M, Franzini A, Felisati G, et al: Deep brain stimulation and cluster headache. Usually bilateral, papilledema may be grossly asymmetric or occasionally unilateral. The addition of acetazolamide or furosemide to the treatment regimen may also improve the headache. Headache is a common symptom, although patients may rarely be discovered incidentally (usually at a routine eye examination) and have no symptoms or only nonspecific visual complaints without headache. Symptomatic Forms of Intracranial Hypertension this list of diseases and conditions associated with both papilledema and increased intracranial pressure has been amended and updated. However, many of the alleged causes of papilledema and increased cerebrospinal fluid pressure are unproved in any rigorous way. Diplopia, a less common symptom,5 is almost always horizontal, and caused by sixth nerve paresis. In patients with vertical diplopia, other diagnoses should be considered, although studies have shown that most sixth nerve palsies commonly have a small vertical component13 that could account for a small diagonal deviation in an otherwise horizontal diplopia. When persistent loss of vision is the presenting complaint, permanent severe visual loss is common. Those rare patients who have elevated intracranial pressure combined with increased intraocular pressure warrant special attention, because the risk of visual loss in these persons appears to be increased. In addition to the enlarged blind spot, they include nasal inferior constriction and steps, arcuate defects, inferior altitudinal loss, and generalized constriction. Kinetic Goldmann perimetry using an Armaly­Drance testing strategy can detect field defects when ~30% of the optic nerve fibers are lost. Fundus photography at the initial and subsequent evaluations is helpful for surveillance of these patients. Typical visual-field disturbances include (a) enlargement of the blind spot (a refractive scotoma); (b) nasal inferior (and less commonly, superior) quadrantic defects; (c) occasional temporal wedge defects; and (d) generalized constriction with preserved visual acuity. Photographs are more accurate than memory (which serves everyone badly), verbal description, or even clinical drawings, which are usually too crude to be truly useful. Signs that may herald new visual deterioration, such as the appearance of multiple infarcts in the disk or new optociliary collateral veins, can be easily detected photographically. Rarely, continuous intracranial pressure monitoring is needed to firmly establish the diagnosis. These include antinuclear antibody, Venereal Disease Research Laboratory or rapid plasmin reagin testing, fluorescent treponemal antibody absorption, and serum calcium determinations to look for evidence of hypoparathyroidism. Other endocrine studies are useful only if adrenal disease or hypoparathyroidism is suspected. By the time serious changes in visual acuity occur, the disease is likely to have caused damage to the papillomacular bundle or collapse of the entire visual field. The mechanisms by which disk swelling due to axoplasmic stasis causes loss of visual acuity is controversial, and may include segmental anterior ischemic optic neuropathy,14,15 subretinal hemorrhage,17 and macular changes secondary to hard exudates. Such patients might benefit from optic nerve sheath fenestration to be sure that visual loss does not occur. Treated with dexamethasone and acetazolamide with rapid resolution of headache and papilledema. Peripapillary folds, which may be observed in instances of chronic swelling of the optic nerve head, are subtly visible. The identification of venous thrombosis in the setting of a hypercoagulable state is an indication for long-term antiocoagulation. Conventional angiography may then be necessary to demonstrate an intracranial venous sinus obstruction or dural arteriovenous malformation. The triangular dark spot denotes clot in the otherwise contrast-enhanced venous sinus. Prolongation of visual-evoked potential latency and central vision loss are among the last manifestations of visual loss due to papilledema. By the time the visual-evoked potential is clearly abnormal, visual acuity is defective and permanent serious visual loss has usually occurred. Until such a trial is undertaken, the drugs of choice remain acetazolamide and furosemide. Acetazolamide, a strong carbonic anhydrase inhibitor, is prescribed at 1000­2000 mg daily (500 mg bid to qid). Furosemide is a weak carbonic anhydrase inhibitor and is prescribed at 40­160 mg/day (20­80 mg bid). Both acetazolamide and furosemide can decrease the frequency and severity of headaches and reduce the incidence of transient visual obscurations. Acetazolamide causes several side effects, including fatigue, nausea, anorexia, and tingling in the hands and feet and around the mouth. In rare instances, acetazolamide treatment may lead to renal stones or acute tubular necrosis, fatal hepatic dysfunction, and aplastic anemia. Potassium wasting occurs with both drugs, although it is more severe with furosemide, and patients may require substantial potassium replacement. Treatment with acetazolamide and furosemide is inappropriate with major venous sinus thrombosis because of the danger of hemoconcentration. Weight gain, hair loss, acne, stretch marks, and a host of other more serious complications may occur. Lowering caloric and sodium intake may be all that is therapeutically required for some asymptomatic patients. Patients should be sent for dietary instruction, and may benefit from commercial diet companies that support gradual weight loss. Vertical-banded gastroplasty and other bariatric operative procedures have been used with mixed success. This firmly establishes the importance of obesity as an etiologic factor in this condition. These bariatric surgical procedures have many complications, however, and should not be taken lightly. Furthermore, anticipation of a painful procedure can lead to unwillingness to return for follow-up. Patients occasionally develop postlumbar puncture headache and may need a blood patch. This conclusion is not intuitive because the person who discovers the tumor may not be the same person who did the lumbar puncture in the first place and the interval between lumbar punctures and tumor appearance may be many years. Early intervention is the most effective means of arresting or reversing visual decline. Macular edema may cause decreased visual acuity, but it is risky to make that call and simply wait for improvement with diuretic treatment. Optic nerve sheath fenestration is also effective in relieving headache in some patients; however, it is less reliable (60­65%) for this purpose than for preserving vision. Such patients should be monitored by an ophthalmologist in conjunction with a neurologist. If visual problems appear, drug therapy should be initiated, preferably with acetazolamide or furosemide. Surgery should be considered if visual loss appears or progresses after medical treatment. Surgery for Visual Loss the preferred surgical procedure is optic nerve sheath fenestration. Optic disk swelling cannot be sustained in the absence of a pressure differential between intraocular and intracranial spaces. Headache Patients whose primary clinical complaint is headache and whose vision loss is slight should be treated with standard medications for migraine headache. Unfortunately, it has many complications and cannot be recommended for any patient who may require subsequent abdominal surgery. Reoperation after lumbar-peritoneal shunt is almost the rule, and the propensity for delayed and unrecognized shunt failure makes it particularly treacherous. No single drug or combination of drugs has been proved effective in randomized prospective trials in preventing progressive visual loss, and no single or combination drug regimen has proved more effective than any other. For patients with long-standing visual loss, atrophic disks, or rapid visual loss, even surgery ­ optic nerve sheath fenestration, lumbar peritoneal shunt, or both ­ cannot always recoup vision or prevent blindness. Pregnancy and Headaches Pregnant patients with severe headaches can be managed with relatively safe treatments during pregnancy, such as repeated lumbar puncture and beta blockers. If headache is incapacitating, bed rest, narcotics, and lumbar peritoneal shunt as a last resort may be considered. If visual loss occurs during pregnancy, optic nerve fenestration is the safest way to preserve vision. Such patients, in my experience, are most commonly black men with systemic hypertension. Although their presenting symptoms may superficially resemble those of malignant hyptertension, these patients do not have the rapid evolution of focal and generalized neurologic findings. Of special importance, however, is the management of elevated blood pressure; it should not be too vigorous until disk swelling has subsided. Drastically lowering the mean arterial blood pressure in a patient with papilledema may cause optic disk infarction. Pediatric Considerations Children are affected in roughly equal ratio of male to female. Many more children have intracranial pressure elevation related to medication or major venous sinus occlusion. Occasional patients have short-lived episodes that resolve within months, but for many the condition lingers for years. These patients need to be followed up at intervals for most of their young adult life. Wall M, George D: Visual loss in Pseudotumor cerebri: Incidence and defects related to visual field strategy. Wall M, George D: Idiopathic intracranial hypertension: a prospective study of 50 patients. In undiagnosed cases exhaustive, expensive, and inconclusive tests and evaluations are apt to be used to ensure that a treatable disease has not been missed. Also, it is useful to try to identify the patient who is malingering and to identify the patient with a functional disorder that is a manifestation of a psychiatric disorder that would justify or even demand referral to a psychiatrist. With knowledge of the clinical profile, a high degree of suspicion, and a use of objective tests based on anatomic and physiological principles, a positive diagnosis of a functional visual disorder can be made. A diagnosis of functional visual loss is an active diagnosis which requires confirmatory findings and should not be decided solely by the failure to find a cause. It should also be kept in mind that functional visual loss can coexist with organic causes of visual loss. Munchausen syndrome or factitious disease ­ is a form of nonorganic visual loss in which patients intentionally induce real symptoms. These patients adopt the role of an ill person and manifest physical symptoms and signs to satisfy this desire. Somatoform disorders ­ these differ from malingering and factitious disorders in that the patient believes that the physical symptoms and signs are organic, i. Complaints are vague but pain and other malfunctions in the body are the main complaints. In this condition, the patients usually misinterpret normal body signals as a sign of disease. Freud thought that hysteria stemmed from emotional disturbances of sexual origin and that visual loss was a conversion from an emotional to a physical reaction. The patients are mostly but not exclusively young women and present with discrete and dramatic manifestations like blindness and paralysis. The main symptoms of visual loss are unilateral or bilateral loss of visual acuity, visual-field loss, or transient visual loss. Other symptoms of nonorganic visual loss include visual illusions and hallucinations, double vision, photophobia, and sensitivity to colors, patterns and moving objects. These include spasm of the near reflex, gaze disturbances, blepharospasm and eye pain. Finally, some patients do not have nonorganic disease per se, but are concerned about nonpathological symptoms such as physiological diplopia or voluntary nystagmus. Nonorganic visual loss is sometimes used when the visual disturbance is not associated with an identifiable organic lesion and no plausible theory exists to explain the disturbance. In a study of 71 consecutive pediatric patients with nonorganic visual loss, it was found that 26. It is essential in the evaluation to document complaints precisely, as inconsistencies in reported symptoms are often key elements in establishing the diagnosis. These patients must be approached with, if anything, extra thoroughness and no shortcuts should be taken during the evaluation. A complete ocular examination may reveal a previously missed or undiagnosed ophthalmologic disorder. Such an examination should include best-corrected visual acuity, pupil size and reactivity, presence of a relative afferent pupillary defect, color vision testing, visual-field analysis by kinetic or static perimetry, ocular motility, slit-lamp biomicroscopy, tonometry, and dilated fundoscopy. It is important to avoid these attitudes and to maintain a friendly, sympathetic approach, while not providing support for unfounded claims of visual loss. Patients are more likely to cooperate in providing historical details and responses to testing if they perceive the physician as supportive and interested in their welfare. Moreover, it is essential to maintain objectivity and to perform a thorough and accurate assessment for both the possibility of true organic disease and the inconsistencies that suggest a nonorganic component. Information regarding intended or pending litigation or disability proceedings may be critical in establishing secondary gain and should be directly requested. Also, the physician should feel comfortable and knowledgeable about the simple bedside tests that can be performed even before sophisticated tests are performed. Examination the examination of patients with suspected nonorganic disease is directed toward three major goals.

References

• Masetti P, Murphy SF, Kouchoukos NT: Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass, J Card Surg 17:485-489, 2002.
• Owen LA, Kowalewski AA, Lessnick SL. EWS/FLI mediates transcriptional repression via NKX2.
• Jirarattanaphochai, K., Jung, S. Nonsteroidal antiinflammatory drugs for postoperative pain management after lumbar spine surgery: a meta-analysis of randomized controlled trials. J Neurosurg Spine 2008;9: 22-31.
• pp. 745n804.
• Budha NR, Frymoyer A, Smelick GS, et al. Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy? Clin Pharmacol Ther 2012;92(2):203- 213.
• Machado RD, Pauciulo MW, Thomson JR, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 2001;68(1):92-102.
• Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insight into prevention of disseminated disease. Rev Infect Dis. 1989;11:755-767.